Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
892
-
Total shares
-
38.6M
-
Shares change
-
+2.35M
-
Total reported value, excl. options
-
$5.3B
-
Value change
-
+$323M
-
Put/Call ratio
-
4.82
-
Number of buys
-
334
-
Number of sells
-
-371
-
Price
-
$137.22
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2024
2 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2024.
ISHARES TR - ISHARES BIOTECH (IBB) has 892 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.6M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (7.63M shares), GOLDMAN SACHS GROUP INC (3.21M shares), MORGAN STANLEY (2.7M shares), CITIGROUP INC (2.59M shares), BNP PARIBAS FINANCIAL MARKETS (2.06M shares), JPMORGAN CHASE & CO (1.61M shares), UBS Group AG (1.44M shares), Royal Bank of Canada (1.32M shares), COMMERCE BANK (722K shares), and Thrivent Financial for Lutherans (677K shares).
This table shows the top 892 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.